Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
ESC Heart Failure|February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartanFrank L Dini, Erberto Carluccio, Roberto Bitto, et al.
European Journal of Heart Failure|June 5, 2024
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial FunctionInês Falcão-Pires, Ana Filipa Ferreira, Fábio Trindade, et al.
Cardiovascular Research|July 28, 2022
From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021/22Paul C Evans, Sean M Davidson, Johann Wojta, et al.
European Journal of Heart Failure|March 11, 2025
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the HeartAlessandra Ghigo, Pietro Ameri, Aarti Asnani, et al.
European Journal of Heart Failure|November 22, 2024
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial DiseasesSophie Van Linthout, Konstantinos Stellos, Mauro Giacca, et al.
Cardiovascular Research|November 15, 2023
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial FunctionMichele Ciccarelli, Inês Falcão Pires, Johann Bauersachs, et al.
European Journal of Heart Failure|June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESCGabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
Cardiovascular Research|July 20, 2020
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the HeartCarlo Gabriele Tocchetti, Pietro Ameri, Rudolf A de Boer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 31, 2024
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESCPetr Peichl, Antoni Bayes-Genis, Thomas Deneke, et al.
European Journal of Haematology|November 6, 2025
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer CentersMarco Picardi, Annamaria Vincenzi, Claudia Giordano, et al.
Pageof 10